We observed an increase in CD47 expression following viral infection (Supplementary Fig. 3c, d), and this effect was replicated in HBECs treated with recombinant human IFN-β (Supplementary Fig. 3e) and IFN-λ1 (Supplementary Fig. 3f). The gene discussed is IFNL1; the disease is viral infectious disease.